Alexandre Lugat, Éric Frampas, Yann Touchefeu, Éric Mirallié, Maëlle Le Bras, Hélène Senellart, Aurore Rauscher, Vincent Fleury, Loïc Campion, Vincent Rohmer, Olivier-François Couturier, Rachida Lebtahi, François Rouzet, Philippe Ruszniewski, Françoise Kraeber-Bodéré, Mickaël Bourgeois, Catherine Ansquer
The aim of this multicentric study was to prospectively compare 68 Ga-DOTANOC PET/CT versus somatostatin receptor scintigraphy (SRS) with SPECT/CT, combined with multiphasic CT scan and MRI in patients with grade 1 or 2 gastroenteropancreatic neuroendocrine tumors (GEP-NET). Patients with histologically proven grade 1 or 2 GEP-NET with suspicion of recurrence or progression, or with typical aspects of GEP-NET on morphological imaging, were explored with conventional imaging (CI): SRS with SPECT/CT, multiphasic CT scan and/or liver MRI followed by 68 Ga-DOTANOC PET/CT...
January 14, 2023: Cancers